tiprankstipranks
Trending News
More News >
Novartis AG (CH:NOVN)
:NOVN
Switzerland Market
Advertisement

Novartis AG (NOVN) Stock Forecast & Price Target

Compare
29 Followers
See the Price Targets and Ratings of:

NOVN Analyst Ratings

Hold
13Ratings
Hold
5 Buy
6 Hold
2 Sell
Based on 13 analysts giving stock ratings to
Novartis
AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NOVN Stock 12 Month Forecast

Average Price Target

CHF102.00
▼(-3.59% Downside)
Based on 13 Wall Street analysts offering 12 month price targets for Novartis AG in the last 3 months. The average price target is CHF102.00 with a high forecast of CHF120.00 and a low forecast of CHF89.00. The average price target represents a -3.59% change from the last price of CHF105.80.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"84":"CHF84","121":"CHF121","93.25":"CHF93.3","102.5":"CHF102.5","111.75":"CHF111.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":120,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF120.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":102,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF102.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":89,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF89.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[84,93.25,102.5,111.75,121],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,104.02,105.24923076923076,106.47846153846153,107.7076923076923,108.93692307692308,110.16615384615385,111.39538461538461,112.62461538461538,113.85384615384615,115.08307692307692,116.31230769230768,117.54153846153847,118.77076923076923,{"y":120,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,104.02,103.86461538461538,103.70923076923077,103.55384615384615,103.39846153846153,103.24307692307693,103.08769230769231,102.93230769230769,102.77692307692307,102.62153846153846,102.46615384615384,102.31076923076922,102.15538461538462,{"y":102,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,104.02,102.86461538461538,101.70923076923077,100.55384615384615,99.39846153846153,98.24307692307693,97.08769230769231,95.93230769230769,94.77692307692308,93.62153846153846,92.46615384615384,91.31076923076924,90.15538461538462,{"y":89,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":93.47,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.19,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.92,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.64,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.28,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.29,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.79,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.08,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.19,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.54,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF120.00Average Price TargetCHF102.00Lowest Price TargetCHF89.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on CH:NOVN
Barclays
Barclays
CHF90
Sell
-14.93%
Downside
Reiterated
10/07/25
Barclays Reaffirms Their Sell Rating on Novartis AG (NOVN)
Deutsche Bank  Analyst forecast on CH:NOVN
Deutsche Bank
Deutsche Bank
CHF120
Buy
13.42%
Upside
Reiterated
10/06/25
Deutsche Bank Keeps Their Buy Rating on Novartis AG (NOVN)
Bank of America Securities Analyst forecast on CH:NOVN
Bank of America Securities
Bank of America Securities
CHF111
Hold
4.91%
Upside
Reiterated
09/26/25
Novartis AG: Balancing Promising Growth Prospects with Policy and Market Challenges
UBS
CHF95
Hold
-10.21%
Downside
Reiterated
09/22/25
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)
TR | OpenAI - 4o Analyst forecast on CH:NOVN
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF109CHF111
Buy
4.91%
Upside
Reiterated
09/20/25
AI Generated ArticleAI Generated Article
Berenberg Bank Analyst forecast on CH:NOVN
Berenberg Bank
Berenberg Bank
CHF89
Hold
-15.88%
Downside
Reiterated
09/17/25
Berenberg Bank Reaffirms Their Hold Rating on Novartis AG (NOVN)
Goldman Sachs Analyst forecast on CH:NOVN
Goldman Sachs
Goldman Sachs
CHF95CHF94
Sell
-11.15%
Downside
Downgraded
09/12/25
Novartis AG Faces Sell Rating Amid Overvaluation and Looming Generic Competition
J.P. Morgan Analyst forecast on CH:NOVN
J.P. Morgan
J.P. Morgan
CHF95
Hold
-10.21%
Downside
Reiterated
09/09/25
J.P. Morgan Reaffirms Their Hold Rating on Novartis AG (NOVN)
Morgan Stanley Analyst forecast on CH:NOVN
Morgan Stanley
Morgan Stanley
CHF100CHF105
Hold
-0.76%
Downside
Reiterated
09/08/25
Morgan Stanley Sticks to Its Hold Rating for Novartis AG (NOVN)
Jefferies
CHF100
Hold
-5.48%
Downside
Reiterated
09/02/25
Jefferies Remains a Hold on Novartis AG (NOVN)
Kepler Capital  Analyst forecast on CH:NOVN
Kepler Capital
Kepler Capital
CHF106
Buy
0.19%
Upside
Reiterated
08/19/25
Kepler Capital Reaffirms Their Buy Rating on Novartis AG (NOVN)
Bernstein
CHF115CHF108
Buy
2.08%
Upside
Reiterated
08/04/25
Bernstein Sticks to Its Buy Rating for Novartis AG (NOVN)
DZ BANK AG Analyst forecast on CH:NOVN
DZ BANK AG
DZ BANK AG
Buy
Reiterated
07/18/25
Novartis AG (NOVN) Gets a Buy from DZ BANK AG
Exane BNP Paribas Analyst forecast on CH:NOVN
Exane BNP Paribas
Exane BNP Paribas
CHF95
Buy
-10.21%
Downside
Initiated
04/16/25
BNP Paribas Exane Starts Novartis (NOVN:SW) (NVS) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Novartis (NOVN:SW) (NYSE: NVS) with a Outperform rating and a price target of CHF95.00.
Stifel Nicolaus Analyst forecast on CH:NOVN
Stifel Nicolaus
Stifel Nicolaus
CHF109
Hold
3.02%
Upside
Reiterated
01/31/25
Novartis AG: Balancing Strong Performance with Future Challenges - Hold Rating Maintained
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on CH:NOVN
Barclays
Barclays
CHF90
Sell
-14.93%
Downside
Reiterated
10/07/25
Barclays Reaffirms Their Sell Rating on Novartis AG (NOVN)
Deutsche Bank  Analyst forecast on CH:NOVN
Deutsche Bank
Deutsche Bank
CHF120
Buy
13.42%
Upside
Reiterated
10/06/25
Deutsche Bank Keeps Their Buy Rating on Novartis AG (NOVN)
Bank of America Securities Analyst forecast on CH:NOVN
Bank of America Securities
Bank of America Securities
CHF111
Hold
4.91%
Upside
Reiterated
09/26/25
Novartis AG: Balancing Promising Growth Prospects with Policy and Market Challenges
UBS
CHF95
Hold
-10.21%
Downside
Reiterated
09/22/25
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)
TR | OpenAI - 4o Analyst forecast on CH:NOVN
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF109CHF111
Buy
4.91%
Upside
Reiterated
09/20/25
AI Generated ArticleAI Generated Article
Berenberg Bank Analyst forecast on CH:NOVN
Berenberg Bank
Berenberg Bank
CHF89
Hold
-15.88%
Downside
Reiterated
09/17/25
Berenberg Bank Reaffirms Their Hold Rating on Novartis AG (NOVN)
Goldman Sachs Analyst forecast on CH:NOVN
Goldman Sachs
Goldman Sachs
CHF95CHF94
Sell
-11.15%
Downside
Downgraded
09/12/25
Novartis AG Faces Sell Rating Amid Overvaluation and Looming Generic Competition
J.P. Morgan Analyst forecast on CH:NOVN
J.P. Morgan
J.P. Morgan
CHF95
Hold
-10.21%
Downside
Reiterated
09/09/25
J.P. Morgan Reaffirms Their Hold Rating on Novartis AG (NOVN)
Morgan Stanley Analyst forecast on CH:NOVN
Morgan Stanley
Morgan Stanley
CHF100CHF105
Hold
-0.76%
Downside
Reiterated
09/08/25
Morgan Stanley Sticks to Its Hold Rating for Novartis AG (NOVN)
Jefferies
CHF100
Hold
-5.48%
Downside
Reiterated
09/02/25
Jefferies Remains a Hold on Novartis AG (NOVN)
Kepler Capital  Analyst forecast on CH:NOVN
Kepler Capital
Kepler Capital
CHF106
Buy
0.19%
Upside
Reiterated
08/19/25
Kepler Capital Reaffirms Their Buy Rating on Novartis AG (NOVN)
Bernstein
CHF115CHF108
Buy
2.08%
Upside
Reiterated
08/04/25
Bernstein Sticks to Its Buy Rating for Novartis AG (NOVN)
DZ BANK AG Analyst forecast on CH:NOVN
DZ BANK AG
DZ BANK AG
Buy
Reiterated
07/18/25
Novartis AG (NOVN) Gets a Buy from DZ BANK AG
Exane BNP Paribas Analyst forecast on CH:NOVN
Exane BNP Paribas
Exane BNP Paribas
CHF95
Buy
-10.21%
Downside
Initiated
04/16/25
BNP Paribas Exane Starts Novartis (NOVN:SW) (NVS) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Novartis (NOVN:SW) (NYSE: NVS) with a Outperform rating and a price target of CHF95.00.
Stifel Nicolaus Analyst forecast on CH:NOVN
Stifel Nicolaus
Stifel Nicolaus
CHF109
Hold
3.02%
Upside
Reiterated
01/31/25
Novartis AG: Balancing Strong Performance with Future Challenges - Hold Rating Maintained
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novartis AG

1 Month
xxx
Success Rate
11/18 ratings generated profit
61%
Average Return
+1.83%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of +1.83% per trade.
3 Months
xxx
Success Rate
19/26 ratings generated profit
73%
Average Return
+3.39%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.08% of your transactions generating a profit, with an average return of +3.39% per trade.
1 Year
David EvansKepler Capital
Success Rate
26/26 ratings generated profit
100%
Average Return
+12.29%
reiterated a buy rating 2 months ago
Copying David Evans's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +12.29% per trade.
2 Years
xxx
Success Rate
26/26 ratings generated profit
100%
Average Return
+18.85%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +18.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NOVN Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
20
20
21
22
12
Hold
18
20
21
26
15
Sell
3
4
2
4
2
Strong Sell
0
0
0
0
0
total
41
44
44
52
29
In the current month, NOVN has received 12 Buy Ratings, 15 Hold Ratings, and 2 Sell Ratings. NOVN average Analyst price target in the past 3 months is 102.00.
Each month's total comprises the sum of three months' worth of ratings.

NOVN Financial Forecast

NOVN Earnings Forecast

Next quarter’s earnings estimate for NOVN is CHF1.79 with a range of CHF1.70 to CHF1.87. The previous quarter’s EPS was CHF1.93. NOVN beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year NOVN has Preformed in-line its overall industry.
Next quarter’s earnings estimate for NOVN is CHF1.79 with a range of CHF1.70 to CHF1.87. The previous quarter’s EPS was CHF1.93. NOVN beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year NOVN has Preformed in-line its overall industry.

NOVN Sales Forecast

Next quarter’s sales forecast for NOVN is CHF11.00B with a range of CHF10.65B to CHF11.41B. The previous quarter’s sales results were CHF11.61B. NOVN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year NOVN has Preformed in-line its overall industry.
Next quarter’s sales forecast for NOVN is CHF11.00B with a range of CHF10.65B to CHF11.41B. The previous quarter’s sales results were CHF11.61B. NOVN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year NOVN has Preformed in-line its overall industry.

NOVN Stock Forecast FAQ

What is CH:NOVN’s average 12-month price target, according to analysts?
Based on analyst ratings, Novartis AG’s 12-month average price target is 102.00.
    What is CH:NOVN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:NOVN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Novartis AG a Buy, Sell or Hold?
        Novartis AG has a consensus rating of Hold, which is based on 5 buy ratings, 6 hold ratings and 2 sell ratings.
          What is Novartis AG’s share price target?
          The average share price target for Novartis AG is 102.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF120.00 ,and the lowest forecast is CHF89.00. The average share price target represents -3.59% Decrease from the current price of CHF105.8.
            What do analysts say about Novartis AG?
            Novartis AG’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Novartis AG?
              To buy shares of CH:NOVN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis